Treatment Groups | Doses (mg/kg) | Creatinine (mg/dL) | Urobilinogen (mg/dL) | Urea (mg/dL) | Albumin (mg/dL) | Protein (mg/dL) |
---|---|---|---|---|---|---|
Naïve | – | 2.74 ± 0.24b | 4.38 ± 0.28b | 103.22 ± 4.55b | 4.56 ± 0.44b | 38.47 ± 1.43b |
Control | – | 5.11 ± 0.65 | 32.20 ± 2.12 | 133.55 ± 6.12 | 18.16 ± 0.85 | 22.95 ± 1.39 |
APHMc | 100 | 3.45 ± 0.12a | 22.25 ± 1.12a | 119.34 ± 3.45a | 11.82 ± 0.34a | 27.53 ± 1.70 |
APHM | 200 | 2.34 ± 0.21b | 13.62 ± 0.57b | 110.76 ± 3.32b | 7.42 ± 0.35b | 33.82 ± 1.72a |
APHM | 300 | 2.56 ± 0.16b | 5.04 ± 0.25b | 104.14 ± 2.85b | 5.08 ± 0.12b | 40.14 ± 1.22b |
Silymarin | 100 | 2.61 ± 0.20b | 10.15 ± 0.85b | 105.58 ± 2.46b | 6.42 ± 0.22b | 35.77 ± 1.44b |